NLRP3 and ulcerative colitis: The capacity of SA to inhibit the activation of the NLRP3 inflammasome was previously reported in rats with diabetic atherosclerosis [101] and in a Kunming mouse model of dextran sodium sulfate-induced ulcerative colitis [102] as well as an intestinal fibrosis model in C57/6BL mice [23].